<sentence id="0">TRAMP , a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95) .</sentence>
<sentence id="1">A novel member of the tumor necrosis factor ( TNF ) receptor family , designated TRAMP , has been identified .</sentence>
<sentence id="2">The structural organization of the 393 amino acid long human TRAMP is most homologous to TNF receptor 1 .</sentence>
<sentence id="3">TRAMP is abundantly expressed on thymocytes and lymphocytes .</sentence>
<sentence id="4">Its extracellular domain is composed of four cysteine-rich domains , and the cytoplasmic region contains a death domain known to signal apoptosis .</sentence>
<sentence id="5">Overexpression of TRAMP leads to two major responses , NF-kappaB activation and apoptosis .</sentence>
<sentence id="6">TRAMP-induced cell death is inhibited by an inhibitor of ICE-like proteases , but <scope type="neg" id="0"><cue type="neg" id="0">not</cue> by Bcl-2</scope> .</sentence>
<sentence id="7">In addition , <scope type="spec" id="2"> <scope type="neg" id="1">TRAMP does <cue type="neg" id="1">not</cue> <cue type="spec" id="2">appear</cue> to interact with any of the known apoptosis-inducing ligands of the TNF family</scope></scope> .</sentence>